141 related articles for article (PubMed ID: 25010949)
1. The clinical course of patients with type 2 diabetes presenting to the hospital with sulfonylurea-induced hypoglycemia.
Braatvedt GD; Sykes AJ; Panossian Z; McNeill D
Diabetes Technol Ther; 2014 Oct; 16(10):661-6. PubMed ID: 25010949
[TBL] [Abstract][Full Text] [Related]
2. Risk of severe hypoglycemia in sulfonylurea-treated patients from diabetes centers in Germany/Austria: How big is the problem? Which patients are at risk?
Schloot NC; Haupt A; Schütt M; Badenhoop K; Laimer M; Nicolay C; Reaney M; Fink K; Holl RW
Diabetes Metab Res Rev; 2016 Mar; 32(3):316-24. PubMed ID: 26409039
[TBL] [Abstract][Full Text] [Related]
3. Risk of hypoglycemia following intensification of metformin treatment with insulin versus sulfonylurea.
Roumie CL; Min JY; Greevy RA; Grijalva CG; Hung AM; Liu X; Elasy T; Griffin MR
CMAJ; 2016 Apr; 188(6):E104-E112. PubMed ID: 26811361
[TBL] [Abstract][Full Text] [Related]
4. A retrospective cross-sectional study of type 2 diabetes overtreatment in patients admitted to the geriatric ward.
Wojszel ZB; Kasiukiewicz A
BMC Geriatr; 2019 Sep; 19(1):242. PubMed ID: 31477024
[TBL] [Abstract][Full Text] [Related]
5. Octreotide: an antidote for sulfonylurea-induced hypoglycemia.
McLaughlin SA; Crandall CS; McKinney PE
Ann Emerg Med; 2000 Aug; 36(2):133-138. PubMed ID: 10918104
[TBL] [Abstract][Full Text] [Related]
6. Patients with diabetes requiring emergency department care for hypoglycaemia: characteristics and long-term outcomes determined from multiple data sources.
Rajendran R; Hodgkinson D; Rayman G
Postgrad Med J; 2015 Feb; 91(1072):65-71. PubMed ID: 25595126
[TBL] [Abstract][Full Text] [Related]
7. Access to emergency room for hypoglycaemia in people with diabetes.
Salutini E; Bianchi C; Santini M; Dardano A; Daniele G; Penno G; Miccoli R; Del Prato S
Diabetes Metab Res Rev; 2015 Oct; 31(7):745-51. PubMed ID: 26044573
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hypoglycemia among a sample of sulfonylurea-treated patients with Type 2 diabetes mellitus in Argentina: The real-life effectiveness and care patterns of diabetes management (RECAP-DM) study.
Gonzalez C; Monti C; Pinzon A; Monsanto H; Ejzykowicz F;
Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):592-602. PubMed ID: 30076124
[TBL] [Abstract][Full Text] [Related]
9. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.
Fasano CJ; O'Malley G; Dominici P; Aguilera E; Latta DR
Ann Emerg Med; 2008 Apr; 51(4):400-6. PubMed ID: 17764782
[TBL] [Abstract][Full Text] [Related]
10. Impact of hypoglycemic events and HbA1c level on sulfonylurea discontinuation and down-titration.
Laires PA; Tang J; Fan CP; Li Z; Qiu Y; Iglay K
Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):213-220. PubMed ID: 27345181
[TBL] [Abstract][Full Text] [Related]
11. Canagliflozin in Conjunction With Sulfonylurea Maintains Glycemic Control and Weight Loss Over 52 Weeks: A Randomized, Controlled Trial in Patients With Type 2 Diabetes Mellitus.
Yale JF; Xie J; Sherman SE; Garceau C
Clin Ther; 2017 Nov; 39(11):2230-2242.e2. PubMed ID: 29103664
[TBL] [Abstract][Full Text] [Related]
12. Hypoglycemia in hospitalized patients treated with sulfonylureas.
Deusenberry CM; Coley KC; Korytkowski MT; Donihi AC
Pharmacotherapy; 2012 Jul; 32(7):613-7. PubMed ID: 22570146
[TBL] [Abstract][Full Text] [Related]
13. Usage pattern, glycemic improvement, hypoglycemia, and body mass index changes with sulfonylureas in real-life clinical practice: results from OBSTACLE Hypoglycemia Study.
Kalra S; Deepak MC; Narang P; Singh V; Uvaraj MG; Agrawal N
Diabetes Technol Ther; 2013 Feb; 15(2):129-35. PubMed ID: 23289432
[TBL] [Abstract][Full Text] [Related]
14. Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes.
McCoy RG; Lipska KJ; Van Houten HK; Shah ND
BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32075810
[TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 Diabetes.
Min JY; Griffin MR; Hung AM; Grijalva CG; Greevy RA; Liu X; Elasy T; Roumie CL
J Gen Intern Med; 2016 Jun; 31(6):638-46. PubMed ID: 26921160
[TBL] [Abstract][Full Text] [Related]
16. HYPERGLYCEMIA AND HYPOGLYCEMIA IN PATIENTS WITH DIABETES IN SKILLED NURSING FACILITIES.
Patell R; Nigmatoulline D; Bena J; Kim DG; Messinger-Rapport B; Lansang MC
Endocr Pract; 2017 Apr; 23(4):458-465. PubMed ID: 28156156
[TBL] [Abstract][Full Text] [Related]
17. Octreotide treatment for sulfonylurea-induced hypoglycaemia.
Crawford BA; Perera C
Med J Aust; 2004 May; 180(10):540-1; author reply 541. PubMed ID: 15139835
[No Abstract] [Full Text] [Related]
18. Association of KCNJ11 E23K gene polymorphism with hypoglycemia in sulfonylurea-treated type 2 diabetic patients.
Ragia G; Tavridou A; Petridis I; Manolopoulos VG
Diabetes Res Clin Pract; 2012 Oct; 98(1):119-24. PubMed ID: 22591706
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study.
Aravind SR; Ismail SB; Balamurugan R; Gupta JB; Wadhwa T; Loh SM; Suryawanshi S; Davies MJ; Girman CJ; Katzeff HL; Radican L; Engel SS; Wolthers T
Curr Med Res Opin; 2012 Aug; 28(8):1289-96. PubMed ID: 22738801
[TBL] [Abstract][Full Text] [Related]
20. Association of Cumulative Multimorbidity, Glycemic Control, and Medication Use With Hypoglycemia-Related Emergency Department Visits and Hospitalizations Among Adults With Diabetes.
McCoy RG; Lipska KJ; Van Houten HK; Shah ND
JAMA Netw Open; 2020 Jan; 3(1):e1919099. PubMed ID: 31922562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
